Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
05/2011
05/26/2011WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011WO2011060488A1 Recombinant microorganisms
05/26/2011WO2011002520A3 Small molecule inhibitors of parp activity
05/26/2011US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors
05/26/2011US20110124694 Bioavailable compositions of metaxalone and processes for producing the same
05/26/2011US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
05/26/2011US20110124600 Use of Dopamine partial agonists for treament of the restless leg syndrome and corresponding pharmaceutical preparation
05/26/2011US20110124572 Syndecan-4 is a regulator of rac1-gtp
05/26/2011US20110124562 Apoaequorin-containing compositions and methods of using same
05/26/2011US20110124558 Novel uses of d-mannopyranose derivatives activating angiogenesis
05/26/2011US20110123619 Buccal delivery system
05/26/2011US20110123608 Pharmaceutical formulation
05/26/2011US20110123599 Aroma therapy patch
05/26/2011US20110123510 Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis
05/26/2011CA2818467A1 Recombinant microorganisms
05/25/2011EP2325317A1 Receptor nucleic acids and polypeptides
05/25/2011EP2324852A1 Therapeutic or prophylactic agent for generalized pain syndrome
05/25/2011EP2324826A1 Hydrophilic amino acid-containing preparation having improved taste
05/25/2011EP1317454B1 Caspase inhibitors and uses thereof
05/25/2011CN102076344A Non-hormonal steroid modulators of nf-kb for treatment of disease
05/25/2011CN101062037B Process for their preparation of thioxanthine derivatives, their use
05/24/2011US7947810 Kits for diagnosing a hypophosphatemic disorder
05/24/2011US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
05/24/2011US7947684 anticoagulants; immunomoderators; antiinflammatory agents
05/24/2011CA2453901C Substituted 4-aminocyclohexanols
05/24/2011CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
05/24/2011CA2412947C Method for treating a movement disorder
05/24/2011CA2393710C Caspase inhibitors and uses thereof
05/24/2011CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
05/24/2011CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein
05/19/2011WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/19/2011WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011WO2011057350A1 Antisense molecules and methods for treating pathologies
05/19/2011WO2011024077A3 Exon skipping therapy for functional amelioration of semi functional dystrophin in becker and duchenne muscular dystrophy
05/19/2011WO2010130799A3 Method for impregnation with supercritical co2
05/19/2011US20110118326 Androgen Receptor Modulator and Uses Thereof
05/19/2011US20110118256 Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions
05/19/2011US20110117226 Uses of conglutin-gamma
05/19/2011US20110117184 Compositions for mucosal delivery of agents
05/19/2011US20110117167 Methods and compositions for soft tissue repair
05/19/2011US20110117075 Thrombin derived peptides for smooth muscle relaxation
05/19/2011US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
05/19/2011CA2780563A1 Antisense molecules and methods for treating pathologies
05/19/2011CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/18/2011EP2322601A1 Method of collecting placental stem cells
05/18/2011EP2322208A2 Bowman-Birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
05/18/2011EP2322199A1 Growth differentiation factor receptors, and methods of using same
05/18/2011EP2322179A1 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
05/18/2011EP2322177A1 Use of a preparation based on nifedipine for treating vaginismus
05/18/2011EP2321282A1 New benzimidazole derivatives
05/18/2011EP2320931A2 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use
05/18/2011CN102066412A Treatment of diseases and conditions mediated by eicosanoids
05/18/2011CN102060941A 6-deoxy alpha-amino acid derivative cyclodextrin, preparation and application thereof
05/18/2011CN102060806A Cytokine inhibitors
05/18/2011CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof
05/18/2011CN102058814A General flavone extractive of four medicaments including grassleaf sweetflag rhizome and preparation method thereof
05/18/2011CN102058747A Process for preparing medicinal powder for spreading muscle and invigorating circulation of blood with superfine pulverizing method
05/18/2011CN102058614A Use of adenosine receptor agonists in therapy
05/18/2011CN102058547A Freeze-dried preparation
05/18/2011CN101642548B Traditional Chinese medicine patch for treating loin and leg pain and preparation method thereof
05/17/2011US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
05/17/2011US7943627 2,4-diaminopyrimidine derivatives
05/17/2011US7943611 Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof
05/17/2011US7943603 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
05/17/2011US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
05/17/2011CA2463552C Treatment of neurodegenerative diseases and cancer of the brain
05/17/2011CA2451521C Use of poly-glu, tyr for neuroprotective therapy
05/17/2011CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs
05/17/2011CA2401385C Protein matrix materials, devices and methods of making and using thereof
05/17/2011CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
05/12/2011WO2011056549A1 Molecular targets and dietary modulators of exercise-induced muscle damage
05/12/2011WO2011055944A2 Methods for treating fibromyalgia syndrome
05/12/2011WO2011054659A1 Exon skipping therapy for dysferlinopathies
05/12/2011US20110112186 Diagnostic methods
05/12/2011US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy
05/12/2011US20110112047 Methods for enhancing muscle performance and tone
05/12/2011US20110111066 Method and composition for improved anabolism
05/12/2011US20110110970 Chimeric vaccines
05/12/2011US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof
05/12/2011CA2779442A1 Methods for treating fibromyalgia syndrome
05/11/2011EP2319870A2 Human antibodies that bind human IL-12 and methods for producing
05/11/2011EP2319838A1 Therapeutic Molecules and Methods-1
05/11/2011EP2318037A2 Method of treating glycogen storage disease
05/11/2011EP1320520B1 Sulfonylguanidine
05/11/2011CN102056907A Heterocyclic derivative and use thereof
05/11/2011CN102056606A Dpp-iv inhibitors for use in the treatment of nafld
05/11/2011CN102048893A Traditional Chinese medicine composition for treating arthromyodynia
05/11/2011CN102048853A Plaster
05/11/2011CN102048852A Oral medicament for treating cerebral infarction and relieving limb spasm
05/11/2011CN102048830A Medicinal liquor for treating rheumatic bone pain
05/11/2011CN102048825A Nux vomica capsules for treating myasthenia gravis and preparation process thereof
05/11/2011CN102048745A Compound sodium aescinate cataplasm
05/11/2011CN102048684A Method for preparing rocuronium bromide injection
05/11/2011CN101530479B Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
05/10/2011US7939670 Nociceptin analogs
05/10/2011US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
05/10/2011US7939099 Sustained improver of muscular fatigue
05/10/2011CA2478335C Amino-methyl substituted tetracycline compounds
05/10/2011CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
05/10/2011CA2417806C New immunoeffector compounds
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 233